Shawkat-Muhialdin Jangi

Statistics

Publications

Citations

196

H-Index

Active since

2004

Affiliations

University of the Basque Country(Current)

Hospital de Cruces

Euskadiko Parke Teknologikoa

Shawkat-Muhialdin Jangi is an author at University of the Basque Country specializing in pharmacology, apoptosis, and histamine receptor pharmacology.

ORCID

Publications per year

2004–2011

Publications

Terfenadine induces apoptosis and autophagy in melanoma cells through ROS-dependent and -independent mechanisms

Francesca Nicolau-Galmés, Aintzane Asumendi, Erika Alonso-Tejerina et al. · APOPTOSIS · 2011 · 77 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

H1 histamine receptor antagonists induce genotoxic and caspase-2-dependent apoptosis in human melanoma cells

Shawkat-Muhialdin Jangi · Carcinogenesis · 2006 · 58 citations

Medicine, Oncology, Pharmacology +13

Terfenadine-induced apoptosis in human melanoma cells is mediated through Ca2+ homeostasis modulation and tyrosine kinase activity, independently of H1 histamine receptors

Shawkat-Muhialdin Jangi, M. Begoña Ruiz‐Larrea, Francesca Nicolau-Galmés et al. · Carcinogenesis · 2007 · 40 citations · Full text

Life Sciences, Oncology, Pharmacology +16

Apoptosis of Human T-Cell Acute Lymphoblastic Leukemia Cells by Diphenhydramine, an H1 Histamine Receptor Antagonist

Shawkat-Muhialdin Jangi, Aintzane Asumendi, Jon Arluzea et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2004 · 21 citations · Full text

Medicine, Oncology, Pharmacology +11

1–4 of 4